DVAX
DYNAVAX TECHNOLOGIES CORP
Key Financials
Operating Income
$-4122000
↑ 88.9%
Revenue
$277.2M
↑ 19.4%
Net Income
$27.3M
↑ 527.4%
EPS (Diluted)
$0.20
↑ 500.0%
Total Assets
$986.3M
↓ 1.1%
Cash & Equivalents
$95.9M
↓ 36.2%
Long-term Debt
$0.00
↓ 100.0%
Total Liabilities
$389.5M
↑ 3.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | DVAX |
| Company Name | DYNAVAX TECHNOLOGIES CORP |
| CIK | 1029142 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 5108485100 |